Larvol Delta - CervoMed-preparing-to-initiate-Phase-3-registrational-trial-in-patients-with-DLB-in-the-second-half-of-2026

neflamapimod (VX-745) - CervoMed

https://www.globenewswire.com/news-release/2025/12/04/3200383/0/en/CervoMed-Announces-Late-Breaking-Data-at-the-18th-CTAD-Conference-Demonstrating-Neflamapimod-Significantly-Slows-Clinical-Progression-in-Dementia-with-Lewy-Bodies.html

Dec 4, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next